Ten Years of Tamoxifen Reduces Breast Cancer Recurrences, Improves Survival
medrev 2017-04-26T12:34:59+00:00For some women with Breast Cancer, taking adjuvant tamoxifen for 10 years after primary treatment leads to a greater reduction in breast cancer recurrences and deaths than taking the drug for only 5 years, according to the results of a large international clinical trial. The findings from the ATLAS trial—presented at the San Antonio Breast Cancer Symposium (SABCS) and published in The [...]
